Fundraising Fox

Amberstone Biosciences

Laguna Hills, US · Delaware corporation

Founders & leadership

GG
George Guikai WuFounder
YS
Yonglei ShangNamed on SEC filing
WZ
Weian ZhaoNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 1 round · 2021

$6MraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George Guikai WuExecutive Officer, Director
  • Yonglei ShangExecutive Officer, Director
  • Weian ZhaoDirector
Offering amount
$12M
Amount sold
$6M
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Amberstone Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2021$1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$300K
National Science FoundationPhase I2019$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Amberstone Biosciences?
Amberstone Biosciences was founded by George Guikai Wu.
How much funding has Amberstone Biosciences raised?
Amberstone Biosciences has disclosed $6M raised across 1 round.
Where is Amberstone Biosciences headquartered?
Amberstone Biosciences is headquartered in Laguna Hills, US.